Treatment of radiation retinopathy following plaque brachytherapy for choroidal melanoma

Current Opinion in Ophthalmology

Volumn 20, Issue 3, 2009, Pages 200-204

  Wen, Joanne C ^a,b,c   McCannel, Tara A ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JULES STEIN EYE INSTITUTE   (United States)

Author keywords

Choroidal melanoma; Radiation maculopathy; Radiation retinopathy; Treatments; Uveal melanoma

Indexed keywords

ANTIBIOTIC AGENT; BEVACIZUMAB; IODINE 125; PALLADIUM 103; PENTOXIFYLLINE; RUTHENIUM 106; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN;

ANTIBIOTIC THERAPY; BRACHYTHERAPY; CANCER RADIOTHERAPY; CATARACT; CATARACT EXTRACTION; CENTRAL RETINA VEIN OCCLUSION; CHOROID MELANOMA; DIABETIC RETINOPATHY; EYE INJURY; EYE PAIN; GLAUCOMA; HUMAN; HYPERBARIC OXYGEN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LASER COAGULATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PTOSIS; RADIATION INJURY; RADIATION RETINA MACULOPATHY; RADIATION RETINOPATHY; RADIOTION RETINA MACULOPATHY; RETINA MACULA DEGENERATION; RETINA MACULA EDEMA; RETINA MACULOPATHY; RETINOPATHY; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; VISUAL ACUITY; CHOROID TUMOR; MELANOMA; RADIATION EXPOSURE; RETINA; RETINA DISEASE;

BRACHYTHERAPY; CHOROID NEOPLASMS; HUMANS; MELANOMA; RADIATION INJURIES; RETINA; RETINAL DISEASES;

EID: 65549159190     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e328329b62d     Document Type: Review

References (37)

1. Archer DB, Amoaku WM, Gardiner TA. Radiation retinopathy: clinical, histo- pathological, ultrastructural and experimental correlations. Eye 1991; 5 (Ft 2): 239-251.
2. Archer DB, Gardiner TA. Ionizing radiation and the retina. Curr Opin Ophthalmol 1994; 5:59-65.
3. Amoaku WM, Archer DB. Fluorescein angiographic features, natural course and treatment of radiation retinopathy. Eye 1990; 4 (Pt 5):657-667.
4. Stack R, Elder M, Abdelaal A, et al. New Zealand experience of 1125 brachytherapy for choroidal melanoma. Clin Experiment Ophthalmol 2005; 33:490-494.
5. Jensen AW, Petersen IA, Kline RW, et al. Radiation complications and tumor control after 125I plaque brachytherapy for ocular melanoma. Int J Radiat Oncol Biol Phys 2005; 63:101 -108.
6. Jones R, Gore E, Mieler W, et al. Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: dose and dose rate effects. Int J Radiat Oncol Biol Phys 2002; 52:989-995.
7. Sia S, Harper C, McAllister I, Perry A. lodine-125 episcleral plaque therapy in uveal melanoma. Clin Experiment Ophthalmol 2000; 28:409-413.
8. Fontanesi J, Meyer D, Xu S, Tai D. Treatment of choroidal melanoma with 1-125 plaque. Int J Radiat Oncol Biol Phys 1993; 26:619-623.
9. Mameghan H, Karolis C, Fisher R, et al. lodine-125 irradiation of choroidal melanoma: clinical experience from the Prince of Wales and Sydney Eye Hospitals. Australas Radiol 1992; 36:249-252.
10. Bosworth JL, Packer S, Rotman M, et al. Choroidal melanoma: 1-125 plaque therapy. Radiology 1988; 169:249-251.
11. Garretson BR, Robertson DM, Earle JD. Choroidal melanoma treatment with iodine 125 brachytherapy. Arch Ophthalmol 1987; 105:1394-1397.
12. Avery RB, Diener-West M, Reynolds SM, et al. Histopathologic characteristics of choroidal melanoma in eyes enucleated after iodine 125 brachytherapy in the collaborative ocular melanoma study. Arch Ophthalmol 2008; 126:207-212.
13. Ferrara N. Vascular endothelial growth factor and the regulation of angiogen- esis. Recent Prog Horm Res 2000; 55:15-35; discussion 35-36.
14. Mason JO 3rd, Albert MA Jr, Persaud TO, Vail RS. Intravitreal bevacizumab
15. treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma. Retina 2007; 27:903-907.Retrospective case study reporting a transient improvement in macular edema and visual acuity following a single injection of intravitreal bevacizumab.
16. FingerPT.Radiationretinopathyistreatablewithantivascularendothelialgrowth
17. factor bevacizumab (Avastin). Int J Radiat Oncol Biol Phys 2008; 70:974-977. This study reported stabilized or improved visual acuity in patients treated with multiple injections of intravitreal bevacizumab.
18. Finger PT, Chin K. Antivascular endothelial growth factor bevacizumab (avastin) for radiation retinopathy. Arch Ophthalmol 2007; 125:751 -756.
19. Gupta A, Muecke JS. Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin). Retina 2008; 28:964-968.
20. Ziemssen F, Voelker M, Altpeter E, et al. Intravitreal bevacizumab treatment of radiation maculopathy due to brachytherapy in choroidal melanoma. Acta Ophthalmol Scand 2007; 85:579-580.
21. Arriola-Villalobos P, Donate-Lopez J, Calvo-Gonzalez C, et al. Intravitreal bevacizumab (Avastin) for radiation retinopathy neovascularization. Acta Ophthalmol Scand 2008; 86:115-116.
22. Solano JM, Bakri SJ, Pulido JS. Regression of radiation-induced macular edema after systemic bevacizumab. Can J Ophthalmol 2007; 42:748-749.
23. Jermak CM, Dellacroce JT, Heffez J, Peyman GA. Triamcinolone acetonide in ocular therapeutics. Surv Ophthalmol 2007; 52:503-522.
24. Gillies MC. Regulators of vascular permeability: potential sites for intervention in the treatment of macular edema. Doc Ophthalmol 1999; 97:251 -260.
25. Shields CL, Demirci H, Dai V, et al. Intravitreal triamcinolone acetonide for radiation maculopathy after plaque radiotherapy for choroidal melanoma. Retina 2005; 25:868-874.24 Sutter FK, Gillies MC. Intravitreal triamcinolone for radiation-induced macular edema. Arch Ophthalmol 2003; 121:1491-1493.
26. Horgan N, Shields CL, Mashayekhi A, et al. Periocular triamcinolone for prevention of macular edema after iodine 125 plaque radiotherapy of uveal
27. melanoma. Retina 2008; 28:987-995. This study reported lower rates of clinical radiation maculopathy following periocular triamcinolone.
28. Hykin PG, Shields CL, Shields JA, Arevalo JF. The efficacy of focal laser therapy in radiation-induced macular edema. Ophthalmology 1998; 105:1425-1429.
29. Kinyoun JL, Chittum ME, Wells CG. Photocoagulation treatment of radiation retinopathy. Am J Ophthalmol 1988; 105:470-478.
30. Kinyoun JL, Zamber RW, Lawrence BS, et al. Photocoagulation treatment for clinically significant radiation macular oedema. Br J Ophthalmol 1995; 79:144-149.
31. Finger PT, Kurli M. Laser photocoagulation for radiation retinopathy after ophthalmic plaque radiation therapy. Br J Ophthalmol 2005; 89:730-738.
32. Bressler NM, Bressler SB. Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences. Invest Ophthalmol Vis Sci 2000; 41:624-628.
33. Bakri SJ, Nickel J, Yoganathan P, Beer PM. Photodynamic therapy for choroidal neovascularization associated with submacular hemorrhage in age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2006; 37:278-283.
34. Lee SC, Song JH, Chung FJ, Kwon OW. Photodynamic therapy of subretinal neovascularization in radiation retinopathy. Eye 2004; 18:745-746.
35. Gall N, Leiba H, Handzel R, Pe'er J. Severe radiation retinopathy and optic neuropathy after brachytherapy for choroidal melanoma, treated by hyperbaric oxygen. Eye 2007; 21:1010-1012.
36. Schmetterer L, Kemmler D, Breiteneder H, et al. A randomized, placebo- controlled, double-blind crossover study of the effect of pentoxifylline on ocular fundus pulsations. Am J Ophthalmol 1996; 121:169-176.
37. Gupta P, Meisenberg B, Amin P, Pomeranz HD. Radiation retinopathy: the role of pentoxifylline. Retina 2001; 21:545-547.